Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 988 across all filing types
Latest filing 2025-04-29 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Notification Letter and Request Form to H Shareholders - Notice of Publication of 2024 Annual Report and 2024 Environmental, Social and Governance Report
Report Publication Announcement Classification · 97% confidence The document is a notification letter to H Shareholders informing them that the Company’s 2024 Annual Report and 2024 Environmental, Social and Governance Report have been published on its website and HKEX’s website, and provides instructions for requesting printed copies. It does not contain the reports themselves but announces their availability. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2025-04-29 English
2024 Environmental, Social and Governance Report
Environmental & Social Information Classification · 91% confidence The document is titled "2024 Environmental, Social and Governance Report" for Pharmaron Beijing Co., Ltd. It covers ESG disclosures, governance structure, sustainability metrics, UN SDGs mapping, performance tables, and assurance, aligning precisely with an ESG/sustainability report. This matches the definition of Environmental & Social Information (Code: SR), which is used for detailed ESG performance reports.
2025-04-29 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO RESIGNATION AND CESSATION OF OFFICE OF NON-EXECUTIVE DIRECTOR
Board/Management Information Classification · 91% confidence The document is a supplemental announcement by the company’s board regarding the voluntary resignation and cessation of office of a non-executive director, citing a change in primary work responsibilities. It falls squarely under ‘Announcement of changes in the company's board of directors or senior management’. Therefore, it is classified as Board/Management Information.
2025-04-29 English
2024 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is explicitly titled '2024 ANNUAL REPORT' for Pharmaron Beijing Co., Ltd. It contains comprehensive financial information, including the Chairman's Statement, Financial Highlights, Management Discussion and Analysis, and the full set of Consolidated Financial Statements (Profit or Loss, Financial Position, Cash Flows, etc.). It is a full-year report covering the fiscal year ended December 31, 2024, which fits the definition of an Annual Report (10-K). FY 2024
2025-04-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2025-04-27 English
(1) RESIGNATION AND CESSATION OF OFFICE OF NON-EXECUTIVE DIRECTOR&#x3b; AND (2) PROPOSED BY-ELECTION OF NON-EXECUTIVE DIRECTOR OF THE THIRD SESSION OF THE BOARD
Board/Management Information Classification · 92% confidence The document is an official announcement disclosing a board-level personnel change — the resignation of a non-executive director and the proposed by-election of a new non-executive director. It does not present financial results or detailed reports but rather communicates changes in the company's board composition, fitting squarely under Board/Management Information (MANG).
2025-04-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.